Bengaluru, India

Balaram Padmanabhan

This inventor holds 1 USPTO granted patent. Top assignees: Hikal Limited, Indian Institute of Science. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Balaram Padmanabhan. Retrieved from https://idiyas.com/inventor/balaram-padmanabhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Balaram Padmanabhan: Innovator in Pharmaceutical Chemistry

Introduction

Balaram Padmanabhan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on gabapentin analogues. His research has implications for the development of new therapeutic agents.

Latest Patents

Balaram Padmanabhan holds a patent for "Gabapentin analogues and process thereof." This invention relates to the compounds trans (E) and cis (Z) stereoisomers of 4-t-butyl gabapentin, along with a process for their preparation. The patent highlights the importance of these stereoisomers in enhancing the efficacy of gabapentin-related treatments.

Career Highlights

Throughout his career, Balaram has worked with prominent organizations such as Hikal Limited and the Indian Institute of Science. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to various research initiatives.

Collaborations

Balaram has collaborated with notable colleagues, including Nagarajan Kuppuswamy and Sivaramakrishnan Hariharan. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Balaram Padmanabhan's work in pharmaceutical chemistry exemplifies the innovative spirit of modern inventors. His contributions, particularly in the area of gabapentin analogues, continue to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…